|
Leucovorin Calcium Clinical Trials
8 actively recruiting trials across 6 locations
▼ -1 trial since August 2026
Also known as: 1492-18-8, 5-Formyl Tetrahydrofolate, Adinepar, CF, Calcifolin +40 more
Pipeline
Phase 1: 2Phase 2: 2Phase 3: 3Phase 1/2: 1
Top Sponsors
- Children's Oncology Group2
- SWOG Cancer Research Network1
- Roswell Park Cancer Institute1
- National Cancer Institute (NCI)1
- NRG Oncology1
Indications
- Cancer8
- Stage IV Pancreatic Cancer AJCC v82
- Refractory Juvenile Myelomonocytic Leukemia1
- Refractory Childhood Myelodysplastic Syndrome1
- Refractory Childhood Acute Myeloid Leukemia1
Birmingham, Alabama3 trials
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Children's Hospital of Alabama
Phase 1
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Hospital of Alabama
Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
University of Alabama at Birmingham Cancer Center
Phase 3
Anchorage, Alaska1 trial
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Anchorage Associates in Radiation Medicine
Phase 2
Gilbert, Arizona1 trial
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Banner MD Anderson Cancer Center
Phase 3
Duarte, California1 trial
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
City of Hope Medical Center
Phase 2
Gainesville, Florida1 trial
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
UF Health Cancer Institute - Gainesville
Phase 1
Buffalo, New York1 trial
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.